Triatomic Capital is a forward-thinking brand that specializes in investing and developing groundbreaking technologies and businesses. They focus on sectors such as engineered biology, new energy, next-gen computing, automated economy, and engineered materials. In the field of engineered biology, Triatomic Capital supports advancements in cell and gene therapies, AI-driven discovery, synthetic biology, multiomic and protein sequencing, as well as early detection methods.

They also invest in new energy solutions, including battery technology and storage, fusion energy, and next-generation nuclear technologies. Triatomic Capital recognizes the importance of next-gen computing and actively supports developments in AI processors, next-gen compute architecture, sensors, scalable quantum computing and optimization, as well as data science platforms. Moreover, they are involved in the automated economy, backing projects that focus on smart contracts, blockchain and cryptocurrency infrastructure, digital rights, software-enabled services, robotics, and security systems.

Lastly, Triatomic Capital is committed to engineered materials, promoting deterministic material design and manufacturing, computational chemistry, and nanomaterials. The inspiration behind the brand's name, Triatomic, comes from the molecule known as a triatomic hydrogen ion (H3+), which plays a crucial role in the formation of stars after the Big Bang. This molecule is also essential for various chemical reactions, including those that lead to the creation of compounds vital for life, such as water and carbon.

Triatomic Capital's headquarters are located at 250 W. 55th St., Suite 1601, New York, NY 10019, with additional locations in the San Francisco Bay Area and Hong Kong. For more information, please refer to their Privacy Policy